Gilead Sciences, Inc. (NASDAQ:GILD) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Gilead Sciences, Inc.

On August 11, Sensex closed 746.29 points or 0.93 percent higher at 80,604.08, and the Nifty ended 221.75 points or 0.91 ...

Wall Street and the Fed will get more insight next week on inflation’s temperature and the economy. The government will ...

Kymera Therapeutics' Q2 2025 earnings call highlights clinical progress, Gilead and Sanofi partnerships, and financial strength, setting a strong stage ...

Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...

Phase 1 healthy volunteer data surpassing Kymera’s target product profile, and further validating its oral, dupilumab-like profile ...

U.S. stocks are drifting near their record heights as Wall Street waits for an upcoming update on inflation.

A wave of factory closures is reshaping regional economies, displacing skilled laborers and weakening supply chains.

Deutsche Bank analyst James Shin raised the firm’s price target on Gilead (GILD) to $135 from $120 and keeps a Buy rating on the shares. Published ...